Bausch Health (BHC) Fundamental Analysis: Revenue, Earnings & Valuation

1.48 / 10

Underperform

Fundamentally the stock underperforms, scoring 1.5/10. Inventory turnover (1.87) and fixed‑asset turnover (5.27) are modest, while accounts receivable turnover (4.52) and tax‑to‑profit ratio (67.3%) are weak. Interest coverage is low (1.24), indicating financial strain.

Analysis Checks(5/10)

Revenue-MV

Value2.18

Score2/3

Weight46.36%

1M Return6.87%

Total operating revenue (YoY growth rate %)

Value6.66

Score1/3

Weight-6.66%

1M Return-1.40%

Inventory turnover ratio

Value1.87

Score2/3

Weight-3.44%

1M Return-0.66%

Accounts receivable turnover ratio

Value4.52

Score1/3

Weight-7.73%

1M Return-1.57%

PB-ROE

Value-0.96

Score1/3

Weight28.99%

1M Return5.22%

Income tax / Total profit (%)

Value67.30

Score1/3

Weight-2.82%

1M Return-0.59%

Fixed assets turnover ratio

Value5.27

Score2/3

Weight-4.90%

1M Return-1.01%

Interest coverage ratio (EBIT / Interest expense) (%)

Value1.24

Score2/3

Weight-3.47%

1M Return-0.73%

Cost of sales ratio (%)

Value29.67

Score3/3

Weight4.32%

1M Return0.79%

Asset-MV

Value-0.55

Score1/3

Weight49.36%

1M Return7.28%

Is BHC undervalued or overvalued?

BHC scores 1.48/10 on fundamentals and holds a Premium valuation at present. Backed by its 570.91% ROE, 1.17% net margin, 11.78 P/E ratio, 4.90 P/B ratio, and 423.08% earnings growth, these metrics solidify its Underperform investment rating.